# FDA recall D-0299-2022

> **Gilead Sciences, Inc.** · Class I · drug recall initiated 2021-12-03.

## Product

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

## Reason for recall

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0299-2022
- **Recalling firm:** Gilead Sciences, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-12-03
- **Report date:** 2022-01-05
- **Termination date:** 2022-07-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Foster City, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0299-2022

## Citation

> AI Analytics. FDA recall D-0299-2022. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0299-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*